What is NanoViricides Inc?
, a clinical stage nano-biopharmaceutical company, discovers, develops, and commercializes drugs to combat viral infections.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical stage nano-biopharmaceutical company, discovers, develops, and commercializes drugs to combat viral infections. The company's product portfolio includes NV-387 drug candidate developed for RSV and influenza indications and has completed phase 1a/1b human clinical trial for the evaluation of safety and tolerability; NV-387 as an active ingredient of drug product formulations for the treatment of COVID infections comprising NV-CoV-2 Oral Syrup and NV-CoV-2 Oral Gummies developed for the treatment of COVID infection; The latter, a semi-solid fixed-dose form, which are in phase 1a/1b human clinical trials for enabling body-weight-based dose titration as is required for pediatric treatments. The company is listed on the AMEX in USA, operating in the Healthcare sector, with a market capitalisation of 31.41M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.